Try our beta test site

Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer

This study has been terminated.
(Follow up period after primary analysis was prematurely stopped because more mature data will not impact the study outcome)
Information provided by (Responsible Party):
CureVac AG Identifier:
First received: February 8, 2013
Last updated: February 15, 2017
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2017
  Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)